Selegiline, also known as L-deprenyl and sold under the brand names Eldepryl and Emsam among others, is a medication which is used in the treatment of Parkinson's disease and major depressive disorder. It is provided in the form of a tablet taken by mouth for Parkinson's disease and as a patch applied to skin for depression
Market Analysis and Insights: Global Selegiline Market
Due to the COVID-19 pandemic, the global Selegiline market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Tablet accounting for % of the Selegiline global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Parkinson's Disease segment is altered to an % CAGR throughout this forecast period.
China Selegiline market size is valued at US$ million in 2021, while the US and Europe Selegiline are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Selegiline landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Selegiline include Apotex, Polpharma, Sanofi-Aventis, Fulton Medicinali, Hexal, Aliud Pharma, Mylan, Novartis and Ratiopharm, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Selegiline capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Selegiline by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Selegiline Scope and Segment
Selegiline market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Selegiline market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Tablet
Capsule
Patch
Segment by Application
Parkinson's Disease
Depression
Attention Deficit Hyperactivity Disorder
Special Populations
By Company
Apotex
Polpharma
Sanofi-Aventis
Fulton Medicinali
Hexal
Aliud Pharma
Mylan
Novartis
Ratiopharm
Teva
Swiss Pharm
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE